WHO ICTRP trial
Trial NL-009254
NL-OMON57734 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON57734 |
|---|---|
| Public title | Trial NL-009254 |
| Scientific title | Trial NL-009254 - N.a. |
| Primary sponsor | Astra Zeneca |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Belgium;Brazil;Japan;Germany;Taiwan;Spain;United Kingdom;Argentina;Chile;China;France;Malaysia;Austria;South… |
| Conditions | gastric or gastro-esophageal junction adenocarcinoma;10017990 |
| Interventions | Publication withdrawn by sponsor |
| Registration date | Feb 6, 2025 |
| Target size | 14 |
| Secondary IDs | NL-009254 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: